Age-dependent differences in the immune response to human metapneumovirus
对人类偏肺病毒的免疫反应存在年龄依赖性差异
基本信息
- 批准号:10700837
- 负责人:
- 金额:$ 4.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2027-08-14
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAdoptive TransferAgeAlveolar MacrophagesBioinformaticsBiological AssayBody Weight decreasedBone MarrowCD8-Positive T-LymphocytesCD8B1 geneCell CommunicationCellsChestChildChimera organismClinicalCoculture TechniquesColorCommunicable DiseasesDataDevelopmentDichloromethylene DiphosphonateDiseaseElderlyEpigenetic ProcessExhibitsFlow CytometryFunctional disorderFundingGenesGenetic TranscriptionGoalsHospitalizationHuman MetapneumovirusImmuneImmune responseImmunityImmunocompromised HostImmunologicsImmunologyImpairmentIn VitroInfectionInflammatoryInfluenzaIsogenic transplantationKnowledgeLabelLaboratoriesLiposomesLiteratureLongevityLower Respiratory Tract InfectionLungMacrophageMediatorMolecular TargetMorbidity - disease rateMusNatural ImmunityNeonatalPathogenesisPathway interactionsPersonsPopulationPopulations at RiskPredispositionPreventionPrimary InfectionPrincipal InvestigatorPulmonary InflammationReportingResearchResearch PersonnelRespiratory DiseaseRespiratory Tract InfectionsRespiratory syncytial virusRoleScientistSeasonsSeveritiesSeverity of illnessSignal TransductionT cell responseT-LymphocyteTechnical ExpertiseTestingTissuesTrainingTranslatingVaccinesViralVirusVirus ReplicationVulnerable PopulationsWeight GainWestern Blottingadaptive immunityage relatedagedcandidate identificationcareercell typechromatin modificationclinical translationcytokineexperimental studyfunctional disabilityimmunoregulationimprovedmonocytemortalitymouse modelmultiple omicsneutralizing antibodynovelpreventprogrammed cell death protein 1reconstitutionrespiratoryrespiratory pathogenrespiratory virussecondary infectionsecondary lymphoid organskillstooltraining opportunity
项目摘要
ABSTRACT
Human metapneumovirus (HMPV) is a leading cause of lower respiratory infections in young children,
immunocompromised persons, and the elderly, resulting in high morbidity and mortality. Few studies have
investigated why HMPV is more severe in the elderly. This proposal aims to fill this knowledge gap about
HMPV pathogenesis. My preliminary data discovered that aged mice infected with HMPV exhibit delayed viral
clearance, increased lung inflammation, and increased CD8+ HMPV-tetramer+ cells co-expressing the
inhibitory markers PD-1, TIM-3, and LAG-3. I hypothesize that severe HMPV infection in the elderly is
caused by impairment of the CD8+ T cell response. In Aim 1, I will investigate the intrinsic causes of the
CD8+ T cell impairment observed in the aged host infected with HMPV using 10X Multiomics studies on murine
lung directly ex vivo and syngeneic transplants. 10X Multiomics will elucidate age-related epigenetic changes
in CD8+ T cells while syngeneic transplants will transfer young CD8+ T cells into an aged host and vice versa to
determine if CD8+ T cells are the primary immune cells causing the impaired immune response to HMPV (i.e.
increased weight loss, clinical severity, delayed viral clearance). In Aim 2, I will investigate extrinsic causes of
the CD8+ T cell impairment, namely by alveolar macrophages (AMs). I will use a 21-color multispectral flow
cytometry panel to enumerate M1 and M2 macrophage populations in the aged host. In vitro co-culture and
transwell assays of AMs and CD8+ T cells will determine if AMs directly impair CD8+ T cells. Selective depletion
of AMs in aged mice and adoptive transfer of young macrophages will determine how AMs contribute to the
impaired immune response in the aged host. 10X Multiomics will also be performed in this aim to investigate
the age-related epigenetic changes in AMs that may contribute to their aberrant M2 accumulation, which I have
also observed in my preliminary data.
This proposal aims to understand the mechanistic differences in the aged host response to HMPV,
which will help elucidate why HMPV infection in the elderly is more severe. These studies have the potential to
translate into the clinical setting and contribute to better management and treatment for HMPV infection, such
as immunomodulation. Identifying molecular targets in the aged host will guide development of a safe and
effective vaccine against HMPV for all at-risk populations.
In addition, this proposal has tremendous training opportunities, contributing towards my career goals of
becoming a clinician scientist and independent principal investigator in immunology and infectious disease.
抽象的
人元病毒(HMPV)是幼儿下呼吸道感染的主要原因,
免疫功能低下的人和老年人,导致高发病和死亡率。很少有研究
研究了为什么HMPV在老年人中更为严重。该建议旨在填补有关此知识的差距
HMPV发病机理。我的初步数据发现,感染HMPV的老年小鼠表现出延迟病毒
清除,肺部炎症增加,CD8+ HMPV四聚体+细胞共表达
抑制标记PD-1,TIM-3和LAG-3。我假设老年人的严重HMPV感染是
由CD8+ T细胞反应受损引起。在AIM 1中,我将研究
使用10倍多组学研究的鼠类感染了HMPV的老年宿主在老年宿主中观察到的CD8+ T细胞损伤
肺直接离体和同性移植。 10倍多组学将阐明与年龄相关的表观遗传变化
在CD8+ T细胞中,同性移植将使年轻的CD8+ T细胞转移到老年宿主中,反之亦然
确定CD8+ T细胞是否是原发性免疫细胞,导致免疫反应受损(即
体重减轻,临床严重程度增加,病毒清除率延迟)。在AIM 2中,我将调查外部原因
CD8+ T细胞损伤,即肺泡巨噬细胞(AMS)。我将使用21色的多光谱流
细胞仪面板以枚举老年宿主中的M1和M2巨噬细胞种群。体外共培养和
AMS和CD8+ T细胞的Transwell分析将确定AMS是否直接损害CD8+ T细胞。选择性耗竭
老年小鼠的AM和年轻巨噬细胞的收养转移将决定AM如何贡献
老年宿主的免疫反应受损。在此目的中,还将执行10倍多组学
与年龄相关的表观遗传变化可能导致其异常M2积累的AM,我拥有的
在我的初步数据中也观察到。
该建议旨在了解老年宿主对HMPV的机理差异,
这将有助于阐明为什么老年人的HMPV感染更为严重。这些研究有可能
转化为临床环境,并为HMPV感染的更好管理和治疗做出贡献,
作为免疫调节。确定老年宿主中的分子靶标将指导安全和
所有高危人群的有效疫苗针对HMPV。
此外,该提议有巨大的培训机会,为我的职业目标做出了贡献
成为免疫学和传染病的临床医生和独立首席研究员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Olivia Parks其他文献
Olivia Parks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Olivia Parks', 18)}}的其他基金
Age-dependent differences in the immune response to human metapneumovirus
对人类偏肺病毒的免疫反应存在年龄依赖性差异
- 批准号:
10462114 - 财政年份:2022
- 资助金额:
$ 4.94万 - 项目类别:
相似海外基金
Pre-Existing Atopy and Respiratory Viral Infections
已有的特应性和呼吸道病毒感染
- 批准号:
10658075 - 财政年份:2023
- 资助金额:
$ 4.94万 - 项目类别:
Role of PD1 blockade and IL-10 during infection in aging
PD1 阻断和 IL-10 在衰老感染过程中的作用
- 批准号:
10509657 - 财政年份:2022
- 资助金额:
$ 4.94万 - 项目类别:
Role of PD1 blockade and IL-10 during infection in aging
PD1 阻断和 IL-10 在衰老感染过程中的作用
- 批准号:
10704181 - 财政年份:2022
- 资助金额:
$ 4.94万 - 项目类别:
Age-dependent differences in the immune response to human metapneumovirus
对人类偏肺病毒的免疫反应存在年龄依赖性差异
- 批准号:
10462114 - 财政年份:2022
- 资助金额:
$ 4.94万 - 项目类别:
Mechanisms of regulatory T-cell mediated endothelial repair following viral pneumonia in aged hosts
老年宿主病毒性肺炎后调节性 T 细胞介导的内皮修复机制
- 批准号:
10687164 - 财政年份:2021
- 资助金额:
$ 4.94万 - 项目类别: